Lorazepam Use Linked to Shorter PFS, OS in Several Cancers
Lorazepam use may impact progression-free survival and overall survival in patients with a range of cancers, new research suggests.
All articles by Julie Ehlers
Avelumab Plus Cabozantinib Appears Safe, Active in Metastatic Clear Cell RCC
Avelumab plus cabozantinib has shown preliminary clinical activity and an acceptable safety profile in metastatic clear cell RCC, according to researchers.
Belzutifan Plus Cabozantinib Deemed Promising for Advanced RCC
Combination treatment with belzutifan and cabozantinib has demonstrated antitumor activity in previously treated, advanced clear cell renal cell carcinoma.
- Loading...
Loading...
Loading... 
Loading...